The impact of current and novel anti-diabetic therapies on cardiovascular risk

Author： Ussher John R Sutendra Gopinath Jaswal Jagdip S

ISSN： 1479-6678

Source： Future Cardiology, Vol.8, Iss.6, 2012-11, pp. : 895-912

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigating the psychosocial impact of anti-HIV combination therapies

By Lee K. Solts B. Burns J.

AIDS Care, Vol. 14, Iss. 6, 2002-12 ,pp. : 851-857

Routledge Ltd

Access to resources Recommend Favorite

Fetuin-A: A Novel Cardiovascular Risk Factor

By Cacciapuoti Federico

Kidney, Vol. 19, Iss. 6, 2010-12 ,pp. : 294-299

Springer Publishing Company

Access to resources Recommend Favorite

Cardiovascular Effects of Current and Future Anti-Obesity Drugs

Current Vascular Pharmacology, Vol. 12, Iss. 3, 2014-01 ,pp. : 493-504

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial(Novel Therapies and Botanical and Mechanical Approaches for Management of Cardiovascular Disease)

Recent Patents on Cardiovascular Drug Discovery, Vol. 8, Iss. 1, 2013-04 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of Traditional Therapies and Biologics on Cardiovascular Diseases in Rheumatoid Arthritis

Current Vascular Pharmacology, Vol. 6, Iss. 3, 2008-07 ,pp. : 218-227

Bentham Science Publishers

Access to resources Recommend Favorite